103 related articles for article (PubMed ID: 6184449)
1. Clonidine prevents methylxanthine stimulation of norepinephrine metabolism in rat brain.
Galloway MP; Roth RH
J Neurochem; 1983 Jan; 40(1):246-51. PubMed ID: 6184449
[TBL] [Abstract][Full Text] [Related]
2. Neuropharmacology of 3-isobutylmethylxanthine: effects on central noradrenergic systems in vivo.
Galloway MP; Roth RH
J Pharmacol Exp Ther; 1983 Oct; 227(1):1-8. PubMed ID: 6194283
[TBL] [Abstract][Full Text] [Related]
3. Noradrenergic modulation of serotonin synthesis and metabolism. II. Stimulation by 3-isobutyl-1-methylxanthine.
Reinhard JF; Galloway MP; Roth RH
J Pharmacol Exp Ther; 1983 Sep; 226(3):764-9. PubMed ID: 6193267
[TBL] [Abstract][Full Text] [Related]
4. Methylxanthine activation of noradrenergic unit activity and reversal by clonidine.
Grant SJ; Redmond DE
Eur J Pharmacol; 1982 Nov; 85(1):105-9. PubMed ID: 6185350
[TBL] [Abstract][Full Text] [Related]
5. Attenuation of isobutylmethylxanthine-induced suppression of operant behavior by pretreatment of rats with clonidine.
Kleven MS; Sparber SB
Pharmacol Biochem Behav; 1987 Oct; 28(2):235-41. PubMed ID: 2446338
[TBL] [Abstract][Full Text] [Related]
6. Clonidine infusions into the locus coeruleus attenuate behavioral and neurochemical changes associated with naloxone-precipitated withdrawal.
Taylor JR; Elsworth JD; Garcia EJ; Grant SJ; Roth RH; Redmond DE
Psychopharmacology (Berl); 1988; 96(1):121-34. PubMed ID: 3147472
[TBL] [Abstract][Full Text] [Related]
7. Clonidine suppresses methylxanthine induced quasi-morphine withdrawal syndrome.
Grant SJ; Redmond DE
Pharmacol Biochem Behav; 1982 Oct; 17(4):655-8. PubMed ID: 6184732
[TBL] [Abstract][Full Text] [Related]
8. Clonidine suppression of noradrenergic hyperactivity during morphine withdrawal by clonidine: biochemical studies in rodents and primates.
Roth RH; Elsworth JD; Redmond DE
J Clin Psychiatry; 1982 Jun; 43(6 Pt 2):42-6. PubMed ID: 6806253
[TBL] [Abstract][Full Text] [Related]
9. Morphine blocks and naloxone enhances suppression of operant behavior by low doses of 3-isobutyl-1-methylxanthine.
Kleven MS; Sparber SB
J Pharmacol Exp Ther; 1989 Jan; 248(1):273-7. PubMed ID: 2464058
[TBL] [Abstract][Full Text] [Related]
10. Clonidine reversal of increased norepinephrine metabolite levels during morphine withdrawal.
Crawley JN; Laverty R; Roth RH
Eur J Pharmacol; 1979 Aug; 57(2-3):247-50. PubMed ID: 573692
[TBL] [Abstract][Full Text] [Related]
11. Noradrenergic and behavioural effects of naloxone injected in the locus coeruleus of morphine-dependent rats and their control by clonidine.
Esposito E; Kruszewska A; Ossowska G; Samanin R
Psychopharmacology (Berl); 1987; 93(3):393-6. PubMed ID: 3124170
[TBL] [Abstract][Full Text] [Related]
12. Clonidine reverses methylxanthine-induced potentiation of baclofen antinociception.
Steardo L; Sawynok J
Pharmacol Biochem Behav; 1985 May; 22(5):905-7. PubMed ID: 2409562
[TBL] [Abstract][Full Text] [Related]
13. Effects of drugs which influence noradrenergic activity on metenkephalin levels in specific brain areas.
Morris B; Livingston A
Neuropeptides; 1986 Jan; 7(1):27-30. PubMed ID: 2419782
[TBL] [Abstract][Full Text] [Related]
14. Total neurochemical lesion of noradrenergic neurons of the locus ceruleus does not alter either naloxone-precipitated or spontaneous opiate withdrawal nor does it influence ability of clonidine to reverse opiate withdrawal.
Caillé S; Espejo EF; Reneric JP; Cador M; Koob GF; Stinus L
J Pharmacol Exp Ther; 1999 Aug; 290(2):881-92. PubMed ID: 10411605
[TBL] [Abstract][Full Text] [Related]
15. Clonidine prevents transient loss of noradrenaline in response to cholinergic hypofunction induced by ethylcholine aziridinium (AF64A).
Hörtnagl H; Potter PE; Singer EA; Kindel G; Hanin I
J Neurochem; 1989 Mar; 52(3):853-8. PubMed ID: 2918312
[TBL] [Abstract][Full Text] [Related]
16. Precipitated diazepam withdrawal elevates noradrenergic metabolism in primate brain.
Grant SJ; Galloway MP; Mayor R; Fenerty JP; Finkelstein MF; Roth RH; Redmond DE
Eur J Pharmacol; 1985 Jan; 107(2):127-32. PubMed ID: 3920054
[TBL] [Abstract][Full Text] [Related]
17. Discriminative stimulus properties of caffeine in the rat: noradrenergic mediation.
Holtzman SG
J Pharmacol Exp Ther; 1986 Dec; 239(3):706-14. PubMed ID: 2432216
[TBL] [Abstract][Full Text] [Related]
18. Plasma and cerebrospinal fluid 3-methoxy-4-hydroxyphenylethylene glycol (MHPG) as indices of brain norepinephrine metabolism in primates.
Elsworth JD; Redmond DE; Roth RH
Brain Res; 1982 Mar; 235(1):115-24. PubMed ID: 7188317
[TBL] [Abstract][Full Text] [Related]
19. Effects of clonidine on desipramine- and desmethylclomipramine-induced 3-methoxy-4-hydroxyphenylglycol levels in rat brain.
Fujita K; Iijima N; Suzuki S; Nakazawa K
Eur J Pharmacol; 1993 Oct; 242(3):301-3. PubMed ID: 8281994
[TBL] [Abstract][Full Text] [Related]
20. Character and meaning of quasi-morphine withdrawal phenomena elicited by methylxanthines.
Collier HO; Cuthbert NJ; Francis DL
Fed Proc; 1981 Apr; 40(5):1513-8. PubMed ID: 6163662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
